Chemomab Therapeutics Ltd.
Hedge Funds Holdings
Last updated:
Chemomab Therapeutics Ltd.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 0.02% of the total amount of its stocks outstanding. This makes up a total of 35.47K shares of Chemomab Therapeutics Ltd.. Compared to the previous quarter, the number fell by -98.93% or -3.27M shares fewer. As for the holding position changes, 50% (2) of current holders sold a part of the shares held, and 75% (3) closed the holdings completely.
Hedge funds holding Chemomab Therapeutics Ltd. (Q1 2021 – Q1 2023)
Q1 2021 | 10 |
---|---|
Q2 2021 | 11 |
Q3 2021 | 14 |
Q4 2021 | 14 |
Q1 2022 | 15 |
Q2 2022 | 13 |
Q3 2022 | 14 |
Q4 2022 | 14 |
Q1 2023 | 4 |
Hedge funds changes in Chemomab Therapeutics Ltd. positions (Q1 2021 – Q1 2023)
Q1 2021 | 10 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q2 2021 | 6 | 1 | 3 | 5 | -4 |
Q3 2021 | 7 | 1 | 4 | 4 | -2 |
Q4 2021 | 2 | 4 | 4 | 2 | 2 |
Q1 2022 | 6 | 4 | 3 | 5 | -3 |
Q2 2022 | 2 | 4 | 1 | 4 | 2 |
Q3 2022 | 3 | 2 | 6 | 1 | 2 |
Q4 2022 | 2 | 4 | 2 | 2 | 4 |
Q1 2023 | 0 | 0 | 2 | 3 | -1 |
Top 50 hedge fund holders of Chemomab Therapeutics Ltd. (NASDAQ:CMMB)
Hedge fund | Value | Shares owned | Portfolio share |
---|---|---|---|
ORBIMED ADVISORS LLC | 6.42M | 2.57M | 0.119% |
CORMORANT ASSET MANAGEMENT, LP | 718K | 288.16K | 0.050% |
IKARIAN CAPITAL, LLC | 612K | 245.89K | 0.122% |
BOOTHBAY FUND MANAGEMENT, LLC | 93K | 37.37K | 0.002% |
STATE STREET CORP | 71K | 28.64K | 0.000% |
CITADEL ADVISORS LLC Ken Griffin | 53K | 21.22K | 0.000% |
ENVESTNET ASSET MANAGEMENT INC | 29K | 11.71K | 0.000% |
GEODE CAPITAL MANAGEMENT, LLC | 29K | 11.73K | 0.000% |
ACTIVEST WEALTH MANAGEMENT | 19K | 7.6K | 0.006% |
ADVISOR GROUP HOLDINGS, INC. | 18K | 6.98K | 0.000% |
MORGAN STANLEY | 15K | 6.2K | 0.000% |
UBS GROUP AG | 12K | 4.88K | 0.000% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 3K | 1.1K | 0.002% |
ROYAL BANK OF CANADA | 1K | 246 | 0.000% |
MEITAV INVESTMENT HOUSE LTD | 0 | 0 | 0.000% |